Daniel H. Daneshvar

Dr. Daniel H. Daneshvar

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2012 in Brain
Verified
Journal Article
Open access
PDF file
AMAnn C. McKee
Ann C. McKee
TSThor Stein
Thor Stein
CNChristopher J. Nowinski
Christopher J. Nowinski
RSRobert A Stern
Robert A Stern
DDDaniel H. Daneshvar
Daniel H. Daneshvar
RCRobert C. Cantu
Robert C. Cantu
Chronic traumatic encephalopathy is a progressive tauopathy that occurs as a consequence of repetitive mild traumatic brain injury. We analysed post-mortem brains obtained from a cohort of 85 subjects with histories of repetitive mild traumatic brain injury and found evidence of chronic traumatic encephalopathy in 68 subjects: all males, ranging in age from 17 to 98 years (mean 59.5 years), including 64 athletes, 21 military veterans (86% of whom were also athletes) and one individual who engaged in self-injurious head banging behaviour. Eighteen age- and gender-matched individuals without a history of repetitive mild traumatic brain injury served as control subjects. In chronic traumatic encephalopathy, the spectrum of hyperphosphorylated tau pathology ranged in severity from focal perivascular epicentres of neurofibrillary tangles in the frontal neocortex to severe tauopathy affecting widespread brain regions, including the medial temporal lobe, thereby allowing a progressive staging of pathology from stages I–IV. Multifocal axonal varicosities and axonal loss were found in deep cortex and subcortical white matter at all stages of chronic traumatic encephalopathy. TAR DNA-binding protein 43 immunoreactive inclusions and neurites were also found in 85% of cases, ranging from focal pathology in stages I–III to widespread inclusions and neurites in stage IV. Symptoms in stage I chronic traumatic encephalopathy included headache and loss of attention and concentration. Additional symptoms in stage II included depression, explosivity and short-term memory loss. In stage III, executive dysfunction and cognitive impairment were found, and in stage IV, dementia, word-finding difficulty and aggression were characteristic. Data on athletic exposure were available for 34 American football players; the stage of chronic traumatic encephalopathy correlated with increased duration of football play, survival after football and age at death. Chronic traumatic encephalopathy was the sole diagnosis in 43 cases (63%); eight were also diagnosed with motor neuron disease (12%), seven with Alzheimer’s disease (11%), 11 with Lewy body disease (16%) and four with frontotemporal lobar degeneration (6%). There is an ordered and predictable progression of hyperphosphorylated tau abnormalities through the nervous system in chronic traumatic encephalopathy that occurs in conjunction with widespread axonal disruption and loss. The frequent association of chronic traumatic encephalopathy with other neurodegenerative disorders suggests that repetitive brain trauma and hyperphosphorylated tau protein deposition promote the accumulation of other abnormally aggregated proteins including TAR DNA-binding protein 43, amyloid beta protein and alpha-synuclein.

25 July 2017 in JAMA
Verified
Journal Article
Open access
PDF file
JMJesse Mez
Jesse Mez
DDDaniel H. Daneshvar
Daniel H. Daneshvar
PKPatrick T. Kiernan
Patrick T. Kiernan
BABobak Abdolmohammadi
Bobak Abdolmohammadi
VAVictor E. Alvarez
Victor E. Alvarez
AMAnn C. McKee
Ann C. McKee
Quiz Ref ID Chronic traumatic encephalopathy (CTE) is a progressive neurodegeneration associated with repetitive head trauma.1-8 In 2013, based on a report of the clinical and pathological features of 68 men with CTE (including 36 football players from the current study), criteria for neuropathological diagnosis of CTE and a staging scheme of pathological severity were proposed.6 Two clinical presentations of CTE were described; in one, the initial features developed at a younger age and involved behavioral disturbance, mood disturbance, or both; in the other, the initial presentation developed at an older age and involved cognitive impairment.9 In 2014, a methodologically rigorous approach to assessing clinicopathological correlation in CTE was developed using comprehensive structured and semistructured informant interviews and online surveys conducted by a team of behavioral neurologists and neuropsychologists.10 In 2015, the neuropathological criteria for diagnosis of CTE were refined by a panel of expert neuropathologists organized by the National Institute of Neurological Disorders and Stroke and the National Institute of Biomedical Imaging and Bioengineering (NINDS-NIBIB).8

1 January 2015
Verified
Book Chapter
Closed access
AMAnn C Mckee
Ann C Mckee
DDDaniel H. Daneshvar
Daniel H. Daneshvar

1 September 2010 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Open access
PDF file
AMAnn C. McKee
Ann C. McKee
BGBrandon E. Gavett
Brandon E. Gavett
RSRobert A Stern
Robert A Stern
CNChristopher J. Nowinski
Christopher J. Nowinski
RCRobert C. Cantu
Robert C. Cantu
ABAndrew E. Budson
Andrew E. Budson
Epidemiological evidence suggests that the incidence of amyotrophic lateral sclerosis is increased in association with head injury. Repetitive head in

1 January 2011 in Clinics in Sports Medicine
Verified
Journal Article
Closed access
DDDaniel H. Daneshvar
Daniel H. Daneshvar
CNChristopher J Nowinski
Christopher J Nowinski
AMAnn C. McKee
Ann C. McKee
RCRobert C. Cantu
Robert C. Cantu

15 January 2017 in Journal of Neurotrauma
Verified
Journal Article
Closed access
PMPhilip H. Montenigro
Philip H. Montenigro
MAMichael L. Alosco
Michael L. Alosco
BMBrett M. Martin
Brett M. Martin
DDDaniel H. Daneshvar
Daniel H. Daneshvar
JMJesse Mez
Jesse Mez
YTYorghos Tripodis
Yorghos Tripodis
The term “repetitive head impacts” (RHI) refers to the cumulative exposure to concussive and subconcussive events. Although RHI are believed to increase risk for later-life neurological consequences (including chronic traumatic encephalopathy), quantitative analysis of this relationship has not yet been examined because of the lack of validated tools to quantify lifetime RHI exposure. The objectives of this study were: 1) to develop a metric to quantify cumulative RHI exposure from football, which we term the “cumulative head impact index” (CHII); 2) to use the CHII to examine the association between RHI exposure and long-term clinical outcomes; and 3) to evaluate its predictive properties relative to other exposure metrics (i.e., duration of play, age of first exposure, concussion history). Participants included 93 former high school and collegiate football players who completed objective cognitive and self-reported behavioral/mood tests as part of a larger ongoing longitudinal study. Using established cutoff scores, we transformed continuous outcomes into dichotomous variables (normal vs. impaired). The CHII was computed for each participant and derived from a combination of self-reported athletic history (i.e., number of seasons, position[s], levels played), and impact frequencies reported in helmet accelerometer studies. A bivariate probit, instrumental variable model revealed a threshold dose-response relationship between the CHII and risk for later-life cognitive impairment ( p < 0.0001), self-reported executive dysfunction ( p < 0.0001), depression ( p < 0.0001), apathy ( p = 0.0161), and behavioral dysregulation ( p < 0.0001). Ultimately, the CHII demonstrated greater predictive validity than other individual exposure metrics.